Crux Biomedical Inc., a Portola Valley, Calif.-based medical device startup from former NeoPath and Bacchus Vascular executive Mel Schatz, has raised around $3.85 million in Series A funding, according to a regulatory filing cited by PE Week. Backers include Alloy Ventures and Dr. Thomas Fogerty.
Update: We see that SiliconTap had the news first.
The audio problem: Learn how new cloud-based API solutions are solving imperfect, frustrating audio in video conferences. Access here